News

The 3rd Athens Medical Leadership and Innovation Conference AMLI 2024, organized by the Athens Medical Group, one of the most important interdisciplinary conferences, which since its inception has become an institution for medical excellence and health, was successfully concluded.

This year’s Conference coincided with the 40th anniversary of the founding of the Athens Medical Group, marking four decades of excellence in the provision of health services, research and medical innovation.

The Conference was hosted from November 22 to 24 at the Athens Concert Hall and more than 200 leading scientists of the Athens Medical Group participated in its proceedings, under the responsibility of a 77-member scientific committee, where they highlighted the medical innovations and pioneers that are already being implemented in the Group’s clinics in Athens and Thessaloniki, as well as the latest developments in all fields of Medicine.

From left: Mr. Christos G. Apostolopoulos, Executive Vice President of the Athens Medical Group, Mr. Marios Themistokleous, Deputy Minister of Health, Dr. George V. Apostolopoulos, President of Athens Medical Group, Dr. Vasilis G. Apostolopoulos, CEO of Athens Medical Group

Through engaging presentations and dynamic panel discussions, participants explored the practical applications of emerging technologies and therapies that are reshaping patient care on an international level.

The conference, which was held online and in person, in collaboration with the Research Institute for Longevity and Prevention of Diseases of Aging, attracted more than 1,200 participants, including distinguished physicians of all specialties, nurses and medical students, confirming the leadership position of Athens Medical Group in the healthcare sector.

During the opening ceremony of the conference, the Management of the Athens Medical Group, the President, Dr. George V. Apostolopoulos, the CEO, Dr. Vasilis G. Apostolopoulos, the Executive Vice President, Mr. Christos G. Apostolopoulos, as well as the Deputy Minister of Health, Mr. Marios Themistocleous, the President of the ISA, Mr. George Patoulis, Mr. Christodoulos Stefanadis, President of the AMLI III Organizing Committee and Mr. Stelios Apostolidis, President of the AMLI III Scientific Committee, delivered speeches.

“Today is an important day, as we celebrate 40 years of contribution by our Group. The heart with the cross and the dove has become synonymous with scientific prestige, trust, safety, and the preservation of human dignity,” said the President and Founder of the Athens Medical Group, Dr. George V. Apostolopoulos, and continued by saying, “For years now, there have been three of us on this journey, all three in everyday life, all three in decisions, all three in all matters like a fist. I thank my fellow travelers, my two children, Vasilis and Christos, who add to the journey, knowledge, enthusiasm, and will for the days to come.”

Dr. George V. Apostolopoulos, President of Athens Medical Group

For his part, the CEO of Athens Medical Group, Dr. Vasilis G. Apostolopoulos, emphasized: “The next step is the evolution of our organization into an organization that produces research, education, helps in the development of treatments and new drugs and plays a decisive role in SE Europe and the Mediterranean. We are investing in Artificial Intelligence, with the sole aim of equipping our Group’s medical staff with better tools, international experience and access to a huge number of cases, so that our doctors can produce the best treatment regimen for their patients, in a holistic and personalized manner. “

The Executive Vice President of the Athens Medical Group, Mr. Christos G. Apostolopoulos, stated: “Since the previous AMLI II Conference, we have invested tens of millions of euros in equipment and facilities, we seized the opportunity to repatriate leading Greek scientists abroad who, together with the leading domestic ones, have us at the scientific pinnacle. We entered into a pioneering international collaboration for European standards and exclusive for Greece with Imperial College Healthcare NHS Trust, as a first step we brought medical students to our hospitals, through our collaboration with the European University of Cyprus, we inaugurated an emblematic investment in Thessaloniki with the new International Oncology Center and we are notwe end there.».

Dr. Vasilis G. Apostolopoulos, CEO of Athens Medical Group

Finally, within the framework of the international strategic partnerships that Athens Medical Group has entered into, two important speeches were held.

The first speech was given by Dr. Cleugh Francesca, Paediatric Emergency Consultant in ED Department & Deputy Director for Innovation and Improvement at Imperial College Healthcare NHS Trust. Dr. Cleugh praised the international collaboration (affiliation) of the Athens Medical Group with Imperial College Healthcare, which promotes cutting-edge developments through the exchange of experiences, specialization, medical know-how and knowledge, strengthening the Group’s position as a leader in the healthcare sector in Europe.

The second speech was by Professor Johnson Elizabeth, Dean of the European University Cyprus, who emphasized the dedication of the Athens Medical Group to education and research, highlighting the valuable opportunities offered to medical students through internships at the Group’s advanced technology hospitals in Athens and Thessaloniki. These opportunities are part of a strategic collaboration, which is the first step towards the establishment of the first private medical school in Greece. This school will combine academic rigor with practical training, preparing future healthcare professionals to meet global standards of excellence.

Mr. Christos G. Apostolopoulos, Executive Vice President of Athens Medical Group

Professor Johnson Elizabeth, Dean of the European University Cyprus

Dr. Cleugh Francesca, Paediatric Emergency Consultant in ED Department & Deputy Director for Innovation and Improvement, Imperial College Healthcare NHS Trust

Excerpt from the 3rd Medical Leadership and Innovation Conference AMLI 2024